Women and girls continue to face gender-based vulnerabilities that require urgent attention - especially in sub-Saharan Africa where 80% of all women living with HIV are located. Improving women and girls access to antiretroviral therapy, HIV and testing and a range of care, treatment and support services (such as screening for cervical cancer or CD4 count diagnoses) requires specific targets and benchmarks for women and girls.
